Aditya Bagrodia, MD, FACS, discusses 3 new drugs and studies for non muscle-invasive bladder cancer that were presented at this year’s AUA meeting, including nadofaragene firadenovec and TAR-200.
Dr. Bagrodia is a urologic oncologist and serves as Associate Professor of Urology at UC San Diego Health, as well as the Disease Team Co-Leader for Genitourinary Cancer.